Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 3, 2023
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy
Nihel Khoudour, Florence Delestre, Fabienne Jabot-Hanin, et al.
Diagnostic and Interventional Imaging
|
April 4, 2024
Differentiation between adrenocortical carcinoma and lipid-poor adrenal adenoma using a multiparametric MRI-based diagnostic algorithm
Carmelia Oloukoi, Anthony Dohan, Martin Gaillard, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatments
Anne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Investigational New Drugs
|
June 2, 2017
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients
Valentine Heidelberger, François Goldwasser, Nora Kramkimel, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 26, 2023
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors
Elisabeth Ashton, Jennifer Arrondeau, Anne Jouinot, et al.
Clinical Genitourinary Cancer
|
October 22, 2019
Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
Marie-Liesse Joulia, Edith Carton, Anne Jouinot, et al.
Pharmaceutics
|
June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
Marie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2018
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma
Giada Poli, Carmen Ruggiero, Giulia Cantini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumab
Laure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
European Journal of Endocrinology
|
October 7, 2022
Corticotroph tumor progression speed after adrenalectomy
Laura Bessiène, Sandrine Moutel, Marine Lataud, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 3, 2023
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy
Nihel Khoudour, Florence Delestre, Fabienne Jabot-Hanin, et al.
Diagnostic and Interventional Imaging
|
April 4, 2024
Differentiation between adrenocortical carcinoma and lipid-poor adrenal adenoma using a multiparametric MRI-based diagnostic algorithm
Carmelia Oloukoi, Anthony Dohan, Martin Gaillard, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatments
Anne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Investigational New Drugs
|
June 2, 2017
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients
Valentine Heidelberger, François Goldwasser, Nora Kramkimel, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 26, 2023
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors
Elisabeth Ashton, Jennifer Arrondeau, Anne Jouinot, et al.
Clinical Genitourinary Cancer
|
October 22, 2019
Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
Marie-Liesse Joulia, Edith Carton, Anne Jouinot, et al.
Pharmaceutics
|
June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
Marie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2018
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma
Giada Poli, Carmen Ruggiero, Giulia Cantini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumab
Laure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
European Journal of Endocrinology
|
October 7, 2022
Corticotroph tumor progression speed after adrenalectomy
Laura Bessiène, Sandrine Moutel, Marine Lataud, et al.
Page
of 9